Parkinson's disease: oxidative stress and therapeutic approaches

被引:84
|
作者
Surendran, Sankar [1 ]
Rajasankar, Srinivasagam [2 ]
机构
[1] LSUHSC, Sch Med, New Orleans, LA 70112 USA
[2] Melmaruvathur Adhi Parasakthi Inst Med Sci, Dept Anat, Melmaruvathur, Tamil Nadu, India
关键词
Parkinson's disease; Antioxidant; Withania somnifera; Neurodegeneration; Canavan disease; MITOCHONDRIAL COMPLEX-I; DOPAMINE-DERIVED SALSOLINOL; N-ACETYLASPARTIC ACID; NITRIC-OXIDE SYNTHASE; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; COENZYME Q(10); UP-REGULATION; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE;
D O I
10.1007/s10072-010-0245-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is a neurodegenerative disorder, caused by reduced levels of catecholamines and oxidative stress. Symptoms seen in the disease include tremor, rigidity, bradykinesia and postural disability. Oxidative stress plays a key role in neurodegeneration and motor abnormalities seen in PD. Altered levels of the protein caused by these changes lead to defective ubiquitin-proteasonne pathway. Neurodegeneration seen in PD and Canavan disease has a common mechanism. Recent studies suggest that herbal medicines can improve molecular changes and motor functions seen in PD.
引用
收藏
页码:531 / 540
页数:10
相关论文
共 50 条
  • [21] Oxidative stress factors in Parkinson's disease
    Dorszewska, Jolanta
    Kowalska, Marta
    Prendecki, Michal
    Piekut, Thomas
    Kozlowska, Joanna
    Kozubski, Wojciech
    NEURAL REGENERATION RESEARCH, 2021, 16 (07) : 1383 - 1391
  • [22] Oxidative stress and the pathogenesis of Parkinson's disease
    Jenner, P
    Olanow, CW
    NEUROLOGY, 1996, 47 (06) : S161 - S170
  • [23] Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease
    Stack, Edward C.
    Ferro, Joellyn L.
    Kim, Jinho
    Del Signore, Steven J.
    Goodrich, Sarah
    Matson, Samantha
    Hunt, Bonnie B.
    Cormier, Kerry
    Smith, Karen
    Matson, Wayne R.
    Ryu, Hoon
    Ferrante, Robert J.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2008, 1782 (03): : 151 - 162
  • [24] Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease
    Beal, M. Flint
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S189 - S194
  • [25] Gene therapeutic approaches to the treatment of Parkinson's disease
    Bowers, WJ
    Maguire-Zeiss, KA
    Harvey, BK
    Federoff, HJ
    CLINICAL NEUROSCIENCE RESEARCH, 2001, 1 (06) : 483 - 495
  • [26] Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease
    Beal, M. F.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S7 - S7
  • [27] Therapeutic approaches in Parkinson's disease andrelated disorders
    Valera, Elvira
    Masliah, Eliezer
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 : 346 - 352
  • [28] Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease
    Jiang, Tianfang
    Sun, Qian
    Chen, Shengdi
    PROGRESS IN NEUROBIOLOGY, 2016, 147 : 1 - 19
  • [29] Target oxidative stress-induced disulfidptosis: novel therapeutic avenues in Parkinson's disease
    Zhang, Junshi
    Liu, Tingting
    Wu, Haojie
    Wei, Jianshe
    Qu, Qiumin
    MOLECULAR BRAIN, 2025, 18 (01)